Garnette Sophia 4
4 · International Stem Cell CORP · Filed Oct 3, 2018
Insider Transaction Report
Form 4
International Stem Cell CORPISCO.OB
Bakalova Sofya
Dir. of Legal Affairs & Oper.
Transactions
- Sale
Common Stock
2018-10-02$1.58/sh−1,494$2,361→ 267 total - Exercise/Conversion
Common Stock
2018-10-02$1.10/sh+1,494$1,643→ 1,761 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-10-02−1,494→ 47,858 totalExercise: $1.10Exp: 2027-05-31→ Common Stock (49,352 underlying)
Footnotes (2)
- [F1]The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share.
- [F2]The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months.